Summary.
1. Antiserum was prepared in the rabbit against synthetic human gastrin I conjugated with bovine serum albumin.
The IgG fraction of this specific antiserum was labelled with FITC (fluoresceine isothiocyanate).
With a direct immunofluorescence technique the distribution of gastrin in the human digestive tract and associated glands was investigated with special reference to extragastric gastrin. 2. Gastrin-containing cells were numerous in the antral mucosa of the human stomach especially in the prepyloric region (2-4cm proximal to the pylorus).
In the body and cardia of the stomach no gastrin-containing cells were seen. 3. Some gastrin-containing cells were seen in the duodenum but fewer than in the antrum and they decreased distally.
4. No gastrin-containing cells were seen in the esophagus, jejunum, ileum and colon. 5. In the pancreas numerous autofluorescent granules were seen, but no specific gastrin-containing cells. Nor could these cells be found in the parotid and submandibular glands.
6. The release of gastrin after immersion in 0.5M glycine solution was investigated. A slight decrease of the specifically fluorescent substance could be seen. A complete release of the substance followed freezing in an isopentane bath in aqueous nitrogen.
ago.
Occurrence and structures of two gastrins, gastrin I and II were elucidated by 1. As gastrin (1964) and secretin (1967) came to be synthesized and other polypeptides could be purified, the physiological effects of these polypeptide hormones as pure or nearly pure substances came to be tested. 2. About 10 kinds of GEP endocrine cells were found electron microscopically whereas others were connected with secretin and other hormones. 3. Specific antiserum to gastrin (pure synthetic human gastrin) was obtained gastro-intestinal tract then could be visualized at the cellular level by immunohisto-Although it has been established both by immunofluorescence and electron microscopy that the gastrin is produced by G cells which are found concentrated in the gastric antrum and pylorus, the occurrence of gastrin and the G cell in other parts of the digestive tract and in some digestive glands has caused much controversy.
It is cells has been very poor. Sections of the antrum were taken just after gastrectomy and distribution of gastrin in the tissue was examined by direct immunofluorescence.
The distribution of gastrin in the normal stomach (antrum, body, cardia), duodenum, jejunum, ileum, colon, rectum, pancreas, parotid gland and submandibular gland was studied by the same method in patients without gastric diseases.
To determine the release of gastrin by glycine, a piece of the antrum, which had been immersed in 0.5M glycine solution for 30min, was also studied by direct immunofluorescence.
Frozen section was studied by the same technique, too.
Immunofluorescence
Direct immunofluorescence technique was applied to formalin-fixed and paraffinembedded tissues. Specific antiserum to synthetic human astrin I was obtained by rated and labelled with FITC by the following procedure:
Preparation of antigen Synthetic human gastrin I (SHG) (Imperial Chemical Industries Ltd.) was coupled (1968a) method. Two mg of bovine serum albumin were dissolved in 2ml of 0.1M potassium phosphate buffer, pH 7.4, containing 1ml of N, N-dimethylformamide.
2mg of 1-ethyl-3-(3-dimethylaminopropyl) carbodiimide were added three times at intervals of 30min.
If necessary, the pH was adjusted to 7.4 with 0.01N hydrochloric acid, then the of carbodiimide were added and stirred at room temperature for 4hrs, after which containing 0.15M sodium chloride. The resultant slightly opalescent solution was it yielded 3.2mg after lyophilization.
Immunization of the rabbit
Two mg of SHG I-bovine serum albumin conjugate in phosphate buffer solution (pH 7.4) was mixed well with complete adjuvant (2ml) until it was completely emulsified. This emulsion was injected into the footpad of the rabbit. Two months later SHG-bovine serum albumin conjugate (1mg) in phosphate buffer solution was injected intravenously as a booster.
Fourteen days after this booster injection a small amount of serum was evaluated by radioimmunoassay and the Ouchterlony agar gel double diffusion test. After the test evidenced the formation of a specific antibody to SHG (Fig. 1) , whole blood was drawn by cardiac puncture.
Preparation
of FITC labeled anti-gastrin antibody ammonium sulfate. Repeatedly dyalized precipitate in buffer was conjugated with with a magnetic stirrer. After dialysis, it was applied to a DEAE cellulose columm, eluted with 0.05M phosphate buffer (pH 6.3) and collected as fraction No. 1. Its protein concentration was 4.8mg/ml and its FP ratio was 1.4.
Direct immunofluorescence technique
Antral mucosa and other tissues were taken immediately after surgery, and small pieces were fixed for 12hrs in cold 10% formaldehyde to be embedded in paraffin.
Paraffin-embedded blocks were sliced and after deparaffinization the sections were washed well with a staining buffer solution (pH 7.4).
Specific anti-gastrin antibody containing globulin labeled with FITC obtained by the above method was layered over the sections for 12hrs. After thorough washing with staining buffer solution, the sections were covered with a cover slide and studied by fluorescence microscopy (Carl Zeiss).
The specificity of the staining was examined by the blocking test with SHG solution. were dispersed in the cryptal epithelium and situated in the middle zone of the mucosal thickness. They were most heavily concentrated in the middle portion (2-4cm proximal to the pylorus) of the antrum and became sparser in the pylorus and beyond. They were pyramidal in shape, extending a long process to the gastric lumen. Gastrin fluorescence generally was more intense in the basal than in the apical cell part.
In the cardia or the body of the stomach there were no gastrin-containing cells.
Duodenum
In the human duodenum gastrin-containing cells could be found as shown in Figures 4 and 5.
The number of gastrin-containing. cells in the human duodenum is definitely lower than in the antrum, and it becomes increasingly lower as the distance from the pylorus.
In the third portion of the duodenum their population was very low (Fig. 5) .
Esophagus, jejunum, ileum, colon and rectum
No gastrin-containing cells could be identified in the esophagus (Fig. 6) , jejunum (Fig. 7) , ileum, colon or rectum. Careful studies were done on fresh specimens of surgically removed pancreas, parotid gland and submandibular gland. Though numerous non-specific autofluorescent granules were demonstrated by fluorescence microscopy, gastrin-containing cells showing specific reaction could not be seen in our study (Fig. 8-10 ).
The distribution of the gastrin-containing cells in the human digestive tract and glands as revealed by this study is summarized in Figure 11 No gastrin-containing cells can be seen in the jejunum, colon or rectum.
gastrin:
1) The molecular weight of gastrin is so low (gastrin I, 2096; gastrin II, 2176) that anti-gastrin antiserum can be obtained only when synthetic gastrin is conjugated with bovine serum alubumin-a chemical problem.
2) Rabbits can be immunized only after long treatment with this gastrin-serum albumin conjugate-an immunological problem. 3) As the anti-gastrin antiserum thus obtained is expensive and small in amount, many investigators have used an indirect immunofluorescence technique.
To avoid non-specific staining caused by this method, a direct immunofluorescence technique should be used-an immunohistochemical problem. In this study a direct immunofluorescence technique was used with the IgG fraction of the specific anti-SHG I antiserum.
In the human stomach gastrin-containing cells are numerous in the antral mucosa of these cells are as described in those papers. This finding was also confirmed in our study in dog salivary glands, which will be reported elsewhere.
